Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Written by Catharine Paddock PhD
Copyright: Medical News Today
Not to be reproduced without the permission of Medical News Today.
"Germline DNA Copy Number Aberrations Identified as Potential Prognostic Factors for Breast Cancer Recurrence"; Yadav
Sapkota, Sunita Ghosh, Raymond Lai, Bradley P. Coe, Carol E. Cass, Yutaka Yasui, John R. Mackey, Sambasivarao Damaraju; PLOS ONE
published 16 Jan 2013;
DOI:10.1371/journal.pone.0053850; Link to Article.
Additional source: University of Alberta Faculty of Medicine and Dentistry
Visit our Breast Cancer category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Paddock, Catharine. "Breast Cancer Recurrence Predictable With Blood Test." Medical News Today. MediLexicon, Intl., 22 Jan. 2013. Web.
20 Apr. 2014. <http://www.medicalnewstoday.com/articles/255233>
Paddock, C. (2013, January 22). "Breast Cancer Recurrence Predictable With Blood Test." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/articles/255233.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT is the registered trade mark of MediLexicon International Limited.